Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | REPL |
---|---|---|
09:32 ET | 5320 | 11.12 |
09:34 ET | 700 | 11.18 |
09:36 ET | 700 | 11.12 |
09:38 ET | 600 | 11.18 |
09:41 ET | 1200 | 11.13 |
09:43 ET | 1400 | 11.1972 |
09:45 ET | 1302 | 11.22 |
09:48 ET | 267 | 11.28 |
09:50 ET | 300 | 11.24 |
09:52 ET | 2112 | 11.29 |
09:54 ET | 1200 | 11.25 |
09:56 ET | 100 | 11.248 |
09:59 ET | 65521 | 11.33 |
10:01 ET | 550 | 11.356 |
10:03 ET | 3645 | 11.26 |
10:06 ET | 640 | 11.22 |
10:08 ET | 500 | 11.22 |
10:10 ET | 740 | 11.16 |
10:12 ET | 813 | 11.13 |
10:14 ET | 507 | 11.165 |
10:15 ET | 200 | 11.165 |
10:17 ET | 100 | 11.165 |
10:19 ET | 100 | 11.165 |
10:21 ET | 700 | 11.165 |
10:24 ET | 100 | 11.2 |
10:26 ET | 2975 | 11.24 |
10:28 ET | 400 | 11.23 |
10:30 ET | 602 | 11.21 |
10:32 ET | 100 | 11.28 |
10:33 ET | 2550 | 11.23 |
10:35 ET | 1023 | 11.3 |
10:37 ET | 245 | 11.31 |
10:39 ET | 5002 | 11.3 |
10:42 ET | 500 | 11.29 |
10:44 ET | 1313 | 11.27 |
10:48 ET | 100 | 11.32 |
10:50 ET | 4265 | 11.42 |
10:51 ET | 1852 | 11.42 |
10:53 ET | 1205 | 11.41 |
10:55 ET | 2981 | 11.41 |
10:57 ET | 209 | 11.405 |
11:00 ET | 2010 | 11.4 |
11:02 ET | 824 | 11.32 |
11:04 ET | 1332 | 11.34 |
11:06 ET | 725 | 11.385 |
11:08 ET | 310 | 11.43 |
11:09 ET | 2712 | 11.42 |
11:11 ET | 3300 | 11.38 |
11:13 ET | 208 | 11.38 |
11:15 ET | 401 | 11.39 |
11:18 ET | 1098 | 11.39 |
11:20 ET | 1061 | 11.38 |
11:22 ET | 370 | 11.375 |
11:24 ET | 100 | 11.38 |
11:26 ET | 100 | 11.38 |
11:27 ET | 756 | 11.38 |
11:29 ET | 2000 | 11.393 |
11:31 ET | 1858 | 11.385 |
11:36 ET | 258 | 11.39 |
11:38 ET | 100 | 11.4 |
11:40 ET | 1700 | 11.41 |
11:42 ET | 200 | 11.41 |
11:44 ET | 4245 | 11.41 |
11:45 ET | 1400 | 11.415 |
11:47 ET | 200 | 11.43 |
11:49 ET | 447 | 11.44 |
11:51 ET | 563 | 11.435 |
11:54 ET | 144 | 11.435 |
11:56 ET | 897 | 11.43 |
11:58 ET | 871 | 11.43 |
12:00 ET | 3076 | 11.48 |
12:02 ET | 761 | 11.48 |
12:03 ET | 467 | 11.49 |
12:05 ET | 5368 | 11.43 |
12:07 ET | 1100 | 11.42 |
12:09 ET | 300 | 11.425 |
12:12 ET | 870 | 11.42 |
12:14 ET | 1100 | 11.415 |
12:16 ET | 1107 | 11.4 |
12:18 ET | 1200 | 11.39 |
12:20 ET | 100 | 11.385 |
12:21 ET | 600 | 11.4 |
12:23 ET | 1804 | 11.39 |
12:25 ET | 22217 | 11.37 |
12:27 ET | 2192 | 11.37 |
12:30 ET | 822 | 11.385 |
12:32 ET | 1797 | 11.39 |
12:34 ET | 100 | 11.38 |
12:38 ET | 1047 | 11.37 |
12:43 ET | 100 | 11.375 |
12:45 ET | 100 | 11.39 |
12:48 ET | 200 | 11.39 |
12:52 ET | 2676 | 11.37 |
12:54 ET | 1155 | 11.365 |
12:57 ET | 1215 | 11.36 |
12:59 ET | 832 | 11.35 |
01:01 ET | 798 | 11.36 |
01:03 ET | 100 | 11.355 |
01:06 ET | 1526 | 11.35 |
01:10 ET | 1293 | 11.33 |
01:12 ET | 693 | 11.3299 |
01:14 ET | 100 | 11.3 |
01:17 ET | 1000 | 11.29 |
01:19 ET | 100 | 11.275 |
01:21 ET | 422 | 11.265 |
01:24 ET | 800 | 11.305 |
01:28 ET | 1597 | 11.29 |
01:30 ET | 1600 | 11.25 |
01:33 ET | 100 | 11.255 |
01:35 ET | 1000 | 11.24 |
01:37 ET | 414 | 11.24 |
01:39 ET | 100 | 11.24 |
01:42 ET | 1755 | 11.23 |
01:44 ET | 1008 | 11.25 |
01:46 ET | 495 | 11.25 |
01:48 ET | 2499 | 11.23 |
01:50 ET | 400 | 11.23 |
01:51 ET | 1000 | 11.245 |
01:53 ET | 1900 | 11.22 |
01:55 ET | 200 | 11.215 |
01:57 ET | 100 | 11.215 |
02:02 ET | 200 | 11.21 |
02:04 ET | 1697 | 11.29 |
02:06 ET | 1937 | 11.29 |
02:09 ET | 1423 | 11.27 |
02:11 ET | 1938 | 11.27 |
02:13 ET | 100 | 11.275 |
02:15 ET | 107 | 11.275 |
02:18 ET | 2085 | 11.26 |
02:20 ET | 100 | 11.26 |
02:22 ET | 1400 | 11.29 |
02:26 ET | 337 | 11.3399 |
02:27 ET | 600 | 11.38 |
02:29 ET | 1690 | 11.36 |
02:31 ET | 1401 | 11.35 |
02:33 ET | 200 | 11.35 |
02:36 ET | 7720 | 11.3 |
02:38 ET | 1118 | 11.34 |
02:42 ET | 400 | 11.39 |
02:44 ET | 515 | 11.39 |
02:45 ET | 407 | 11.4 |
02:47 ET | 1066 | 11.38 |
02:49 ET | 1324 | 11.38 |
02:51 ET | 2866 | 11.35 |
02:54 ET | 3968 | 11.31 |
02:56 ET | 3820 | 11.32 |
02:58 ET | 1950 | 11.32 |
03:00 ET | 2158 | 11.31 |
03:02 ET | 1621 | 11.3 |
03:03 ET | 1778 | 11.33 |
03:07 ET | 116 | 11.33 |
03:09 ET | 1947 | 11.35 |
03:12 ET | 9936 | 11.32 |
03:14 ET | 600 | 11.31 |
03:16 ET | 108 | 11.31 |
03:20 ET | 2379 | 11.25 |
03:21 ET | 200 | 11.23 |
03:23 ET | 608 | 11.24 |
03:25 ET | 1862 | 11.24 |
03:27 ET | 400 | 11.23 |
03:30 ET | 700 | 11.24 |
03:32 ET | 4760 | 11.22 |
03:34 ET | 3450 | 11.19 |
03:36 ET | 2012 | 11.22 |
03:38 ET | 2030 | 11.23 |
03:39 ET | 4145 | 11.24 |
03:41 ET | 1071 | 11.251 |
03:43 ET | 3234 | 11.28 |
03:45 ET | 3727 | 11.27 |
03:48 ET | 5317 | 11.26 |
03:50 ET | 1106 | 11.25 |
03:52 ET | 6143 | 11.19 |
03:54 ET | 9561 | 11.185 |
03:56 ET | 11011 | 11.175 |
03:57 ET | 21572 | 11.145 |
03:59 ET | 152110 | 11.13 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Replimune Group Inc | 756.3M | -3.4x | --- |
Rapport Therapeutics Inc | 743.2M | 0.0x | --- |
Erasca Inc | 774.1M | -2.9x | --- |
MBX Biosciences Inc | 737.7M | -16.5x | --- |
Arrivent Biopharma Inc | 776.2M | -9.5x | --- |
Terns Pharmaceuticals Inc | 780.7M | -6.7x | --- |
Replimune Group, Inc. a clinical-stage biotechnology company engaged in the development of a novel class of oncolytic immunotherapies. The Company’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. RP1 (vusolimogene oderparepvec) is its lead product candidate and is based on a proprietary strain of herpes simplex virus engineered and genetically armed with a fusogenic protein (GALV-GP R-) and GM-CSF intended to maximize tumor killing potency, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response. It is also developing additional product candidates, RP2 and RP3, to enhance anti-tumor immune responses and are intended to address additional tumor types, including traditionally less immune responsive tumor types. RP2 additionally expresses an anti-CTLA-4 antibody-like molecule, as well as GALV-GP R- and GM-CSF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $756.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 68.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.21 |
EPS | $-3.27 |
Book Value | $6.10 |
P/E Ratio | -3.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.